ArticleFrontiers in microbiology2026
Residual based anomaly detection framework for variant caller dispatch in DNA sequencing data.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reliable and scalable variant analysis is an enabling component of genomic studies involving microbial communities, host-associated microorganisms, and their hosts, and may support future investigations of genetic heterogeneity within symbiotic systems. Widely used workflows incorporating BWA and GATK provide standardized default processing routes, but their performance may vary across genomic regions containing repetitive sequences, complex structures, or atypical local sequence characteristics. Applying a context-aware software-recommendation procedure to every genomic region, however, can substantially increase computational demand. Here, we present LSTM-EWMA, a screening-and-dispatch framework designed to identify genomic regions that should be considered for specialized downstream evaluation. The framework represents ordered genomic regions as a sequence of feature vectors, uses a Long Short-Term Memory (LSTM) network trained exclusively on predefined in-control (IC) regions to model baseline patterns, and applies an Exponentially Weighted Moving Average (EWMA) control chart to standardized prediction residuals. Regions exceeding prespecified control limits are operationally labeled as out-of-control (OC) and designated as candidates for downstream software recommendation, whereas unflagged regions remain on the default processing path. These labels describe computational workflow states and do not independently confirm genomic variants or biological abnormalities. Using simulated sequencing data derived from the human reference genome as an initial methodological benchmark, LSTM-EWMA distinguished predefined OC regions from IC regions while maintaining a low observed false-alarm rate under the evaluated settings. These findings support the feasibility of the dispatch strategy within the current simulation design and provide a defined basis for subsequent evaluation in microbial, metagenomic, and host-associated sequencing contexts. With further validation across taxonomically diverse and biologically characterized datasets, LSTM-EWMA could support scalable variant-analysis workflows for microbial community and symbiosis research. The source code is publicly available at https://github.com/Icarus200110/Lstm-EWMA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.